These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 34211853)
1. Regulatory Network Analysis of Mutated Genes Based on Multi-Omics Data Reveals the Exclusive Features in Tumor Immune Microenvironment Between Left-Sided and Right-Sided Colon Cancer. Yi T; Zhang Y; Ng DM; Xi Y; Ye M; Cen L; Li J; Fan X; Li Y; Hu S; Rong H; Xie Y; Zhao G; Chen L; Chen C; Ni S; Mi J; Dai X; Liao Q Front Oncol; 2021; 11():685515. PubMed ID: 34211853 [TBL] [Abstract][Full Text] [Related]
2. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data. Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572 [TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis reveals the landscape of tumor microenvironments in left-sided and right-sided colon cancer. Liu D; Li C; Deng Z; Luo N; Li W; Hu W; Li X; Qiu Z; Chen J; Peng J Front Med (Lausanne); 2024; 11():1403171. PubMed ID: 39267963 [TBL] [Abstract][Full Text] [Related]
4. Analysis of multi-omics differences in left-side and right-side colon cancer. Huang Y; Duanmu J; Liu Y; Yan M; Li T; Jiang Q PeerJ; 2021; 9():e11433. PubMed ID: 34026368 [TBL] [Abstract][Full Text] [Related]
5. Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer. Hu W; Yang Y; Li X; Huang M; Xu F; Ge W; Zhang S; Zheng S Mol Cancer Res; 2018 Mar; 16(3):476-485. PubMed ID: 29187560 [TBL] [Abstract][Full Text] [Related]
6. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686 [TBL] [Abstract][Full Text] [Related]
7. Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods. Jiang Y; Yan X; Liu K; Shi Y; Wang C; Hu J; Li Y; Wu Q; Xiang M; Zhao R BMC Cancer; 2020 Oct; 20(1):1012. PubMed ID: 33076847 [TBL] [Abstract][Full Text] [Related]
8. Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles. Imperial R; Ahmed Z; Toor OM; Erdoğan C; Khaliq A; Case P; Case J; Kennedy K; Cummings LS; Melton N; Raza S; Diri B; Mohammad R; El-Rayes B; Pluard T; Hussain A; Subramanian J; Masood A Mol Cancer; 2018 Dec; 17(1):177. PubMed ID: 30577807 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of circulating immune cells in left- and right-sided colon cancer. Di J; Zhuang M; Yang H; Jiang B; Wang Z; Su X PeerJ; 2017; 5():e4153. PubMed ID: 29230377 [TBL] [Abstract][Full Text] [Related]
10. Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis. Peng Q; Lin K; Chang T; Zou L; Xing P; Shen Y; Zhu Y Onco Targets Ther; 2018; 11():609-618. PubMed ID: 29430186 [TBL] [Abstract][Full Text] [Related]
11. Comparison of clinicopathological features and Xue X; Li X; Pan Z; Zhao L; Ding Y Int J Clin Exp Pathol; 2017; 10(11):11353-11359. PubMed ID: 31966490 [TBL] [Abstract][Full Text] [Related]
12. Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis. Nitsche U; Stögbauer F; Späth C; Haller B; Wilhelm D; Friess H; Bader FG Dig Surg; 2016; 33(2):157-63. PubMed ID: 26824772 [TBL] [Abstract][Full Text] [Related]
13. Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer. Hu Y; Ding J; Wu C; Gao H; Ge M; Shao Q; Liu Y; Ye Q Front Oncol; 2022; 12():845765. PubMed ID: 35936748 [TBL] [Abstract][Full Text] [Related]
14. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers. Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803 [TBL] [Abstract][Full Text] [Related]
15. Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location. Wang QY; Zhong WT; Xiao Y; Lin GL; Lu JY; Xu L; Zhang GN; Du JF; Wu B World J Gastroenterol; 2024 Sep; 30(33):3823-3836. PubMed ID: 39351432 [TBL] [Abstract][Full Text] [Related]
16. Impact of primary colorectal Cancer location on the KRAS status and its prognostic value. Xie MZ; Li JL; Cai ZM; Li KZ; Hu BL BMC Gastroenterol; 2019 Mar; 19(1):46. PubMed ID: 30917791 [TBL] [Abstract][Full Text] [Related]
17. Characterization of genomic alterations in Chinese colorectal cancer patients. Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological differences and correlations between right and left colon cancer. Kalantzis I; Nonni A; Pavlakis K; Delicha EM; Miltiadou K; Kosmas C; Ziras N; Gkoumas K; Gakiopoulou H World J Clin Cases; 2020 Apr; 8(8):1424-1443. PubMed ID: 32368535 [TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity of guanine nucleotide binding-protein γ subunit 4 in left- and right-sided colon cancer. Song J; Yang J; Lin R; Cai X; Zheng L; Chen Y Oncol Lett; 2020 Dec; 20(6):334. PubMed ID: 33123245 [TBL] [Abstract][Full Text] [Related]
20. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer. Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]